A critical platform technology to synthesise drug compounds at scale – and onshore production in Australia – has been successfully demonstrated in a collaboration between Melbourne company Boron Molecular, and innovation and technology development specialists, DMTC Limited, with support from Australia’s national science agency, CSIRO.
Defence prime BAE Systems Australia is working with DMTC Limited and research partners to support local small to medium enterprises (SMEs) to adopt new technologies that will drive future shipbuilding.
DMTC Limited and the Australian Academy of Technological Sciences and Engineering (ATSE) are proud to jointly announce Dr Claretta DSouza as the 2024 recipient of the DMTC Guest of the Chair Fellowship.
BlueScope electrical engineer and ATSE Elevate scholar Yang-Ming Goh has successfully completed the first DMTC Guest of the Chair Fellowship.
In February, DMTC returned to Canberra for its 2024 Annual Conference.
Bringing together individuals from across the defence innovation and science & technology ecosystems, the aim of this year’s Annual Conference was to highlight significant advancements in Australia’s sovereign industrial capability while celebrating the collaborative efforts of individuals, teams and partners from across DMTC’s diverse portfolio of programs and projects.
The Conference also served as a forum for broader strategic discussions, including reflections on the implications of the Defence Strategic Review and associated initiatives, how stakeholders can best manage this period of transition and uncertainty, and overcoming the practical hurdles confronting the defence sector in delivering asymmetric capability.
DMTC Limited
DMTC is a not-for-profit company that designs, manages and leads multi-party R&D initiatives that deliver enhanced defence, national security and health security capabilities, and strengthen Australia’s industrial capacity.
Quick Links
